SAN FRANCISCO, April 18, 2018 -- Adam J. Epstein, founder of Third Creek Advisors, LLC, will be a panelist at the Securities and Exchange Commission (SEC) Roundtable On Market Structure For Thinly-Traded Securities at the SEC’s headquarters in Washington, D.C. on April 23, 2018. The purpose of the event is to discuss the challenges faced by participants in the market for thinly-traded exchange-listed securities and potential improvements that might be considered to the market structure for these securities.
The roundtable will open with remarks from Brett Redfearn, Director, Division of Trading and Markets. Following, Mr. Epstein will be speaking on the panel entitled “Challenges in Market Structure Performance of Thinly-Traded Exchange-Listed Equity Securities.” The roundtable will be open to the public and webcast live on SEC.gov.
“Illiquidity is a dire problem for thousands of public companies in the United States; it negatively impacts capital formation, job growth, and, ultimately, innovation,” commented Mr. Epstein. “I applaud the SEC for its diligence in addressing this issue in such a fulsome fashion, and I’m honored to participate.”
When: Monday, April 23, 2018, 9:30 a.m.
Where: Securities and Exchange Commission, Multi-Purpose Room LL-006,
100 F Street, NE, Washington, D.C. 20549
Topic: “Challenges in Market Structure Performance of Thinly-Traded Exchange-Listed Equity Securities”
Panelists:
Steve Cavoli, Senior Vice President, Virtu Financial
Adam J. Epstein, Founder, Third Creek Advisors, LLC
Brian Fagen, Head of Execution Strategy, Deutsche Bank
Bryan Harkins, E.V.P. and Head of U.S. Markets, CboeBZX
Frank Hathaway, Chief Economist, Nasdaq
Ovi Montemayor, Managing Director, Financial Markets Services, TD Ameritrade
Ari Rubenstein, CEO, GTS Securities
Jason Vedder, Director of Global Trading & Operations, Driehaus Capital Management
About Third Creek Advisors, LLC
Third Creek Advisors, LLC partners with CEOs and boards to help them master the small-cap issues institutional investors care most about. Third Creek’s founder, Adam J. Epstein, co-managed a special situation hedge fund that invested in more than 500 small-cap financings. Epstein is the author of The Perfect Corporate Board: A Handbook for Mastering the Unique Challenges of Small-Cap Companies (McGraw Hill, 2012), and contributing author to The Handbook of Board Governance: A Comprehensive Guide for Public, Private and Not for Profit Board Members (Wiley, 2016). In June 2017, The Perfect Corporate Board was the “#1 Best Seller” in the corporate governance vertical on Amazon.com. For more information and exclusive content visit http://www.thirdcreekadvisors.com, or connect on LinkedIn.
Contact: Adam J. Epstein [email protected]


Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid 



